- Home
- MDU vs DNLI Comparison
MDU vs DNLI Comparison
Compare MDU & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDU | DNLI |
|---|---|---|
| Founded | 1924 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.7B |
| IPO Year | 1994 | 2017 |
Fundamental Metrics
Financial Performance| Metric | MDU | DNLI |
|---|---|---|
| Price | $21.17 | $22.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 14 |
| Target Price | $21.67 | ★ $34.33 |
| AVG Volume (30 Days) | 1.6M | ★ 2.0M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.55% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $1,875,066,000.00 | N/A |
| Revenue This Year | $7.52 | N/A |
| Revenue Next Year | $6.00 | $408.85 |
| P/E Ratio | $54.49 | ★ N/A |
| Revenue Growth | ★ 6.66 | N/A |
| 52 Week Low | $15.76 | $12.58 |
| 52 Week High | $22.98 | $27.30 |
Technical Indicators
Market Signals| Indicator | MDU | DNLI |
|---|---|---|
| Relative Strength Index (RSI) | 49.47 | 44.38 |
| Support Level | $19.99 | $18.27 |
| Resistance Level | $21.27 | $23.27 |
| Average True Range (ATR) | 0.42 | 1.39 |
| MACD | 0.04 | -0.45 |
| Stochastic Oscillator | 53.69 | 17.39 |
Price Performance
Historical ComparisonAbout MDU MDU Resources Group Inc. (Holding Company)
MDU Resources Group Inc is a pure-play regulated energy delivery business. It is organized into three reportable business segments: Electric, Natural Gas Distribution, and Pipeline. Maximum revenue is generated from the Pipeline segment, which provides natural gas transportation and underground storage services through a FERC-regulated pipeline system mainly in the Rocky Mountain and northern Great Plains regions of the United States. This segment also provides non-regulated energy-related services, including cathodic protection. The electric segment generates, transmits, and distributes electricity in Montana, North Dakota, South Dakota, and Wyoming, and the natural gas distribution segment distributes natural gas in those states, as well as in Idaho, Minnesota, Oregon, and Washington.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.